Showing results (11-20 of 421) with videos related to
Sort By:
Pageof 43
Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2001
Everolimus. NovartisF J DumontCellular Immunology|April 1, 1987
Divergent effects of cyclosporine A on interferon- and mitogen-induced Ly-6A antigen suggest autocrine regulation of Ly-6A expression in activated T cellsF J DumontCurrent Opinion in Investigational Drugs (London, England : 2000)|August 31, 2001
Alemtuzumab (Millennium/ILEX)F J DumontCurrent Medicinal Chemistry|March 7, 2000
FK506, an immunosuppressant targeting calcineurin functionF J DumontCurrent Opinion in Molecular Therapeutics|July 22, 2004
Technology evaluation: abatacept, Bristol-Myers SquibbFrancis J DumontIdrugs : the Investigational Drugs Journal|March 18, 2005
Fingolimod. Mitsubishi Pharma/NovartisFrancis J DumontIdrugs : the Investigational Drugs Journal|August 23, 2005
BMS-188667 (Bristol-Myers Squibb)F J DumontTransfusion|June 1, 1991
Sampling errors and the precision associated with counting very low numbers of white cells in blood componentsL J DumontJournal of the American Podiatric Medical Association|March 21, 2009
Diagnosis and prevalence of onychomycosis in diabetic neuropathic patients: an observational studyIsabelle J DumontJournal De Biologie Buccale|March 1, 1976
[Ultrastructural study of human pulp cells cultured in vitro]H Magloire, J DumontPageof 43